BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21034351)

  • 1. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
    Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K; Kołodziejczyk Z
    Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary OPN excretion in children with glomerular proteinuria.
    Wasilewska A; Taranta-Janusz K; Kuroczycka-Saniutycz E; Zoch-Zwierz W
    Adv Med Sci; 2011; 56(2):193-9. PubMed ID: 21983451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome].
    Kiliś-Pstrusińska K; Zwolińska D; Medyńska A; Wawro A; Kordecki H
    Przegl Lek; 2006; 63 Suppl 3():198-200. PubMed ID: 16898529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal biopsy criterion in children with asymptomatic constant isolated proteinuria.
    Hama T; Nakanishi K; Shima Y; Mukaiyama H; Togawa H; Tanaka R; Hamahira K; Kaito H; Iijima K; Yoshikawa N
    Nephrol Dial Transplant; 2012 Aug; 27(8):3186-90. PubMed ID: 22231035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome.
    Kiliś-Pstrusińska K; Medyńska A; Zwolińska D; Wawro A
    Kidney Blood Press Res; 2008; 31(2):122-6. PubMed ID: 18391570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies.
    Dantas M; Romão EA; Costa RS; dos Reis MA; Vieira Neto OM; Ribeiro RA; Ravinal RC; Rodrigues Júnior AL; Coimbra TM
    Kidney Blood Press Res; 2007; 30(5):306-13. PubMed ID: 17804911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary fibronectin excretion as a marker of disease activity in children with IgA nephropathy and Henoch-Schönlein nephropathy].
    Roszkowska-Blaim M; Mizerska-Wasiak M; Bartłomiejczyk I
    Przegl Lek; 2006; 63 Suppl 3():90-3. PubMed ID: 16898499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis.
    Besbas N; Kalyoncu M; Cil O; Ozgul RK; Bakkaloglu A; Ozaltin F
    Ren Fail; 2015; 37(9):1435-9. PubMed ID: 26335292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
    Wasilewska A; Zoch-Zwierz W; Tenderenda E
    Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal disorders involved in the pathophysiology of urinary excretion of a-1 microglobulin in patients with glomerulopathies.
    Romão EA; Coimbra TM; Costa RS; Vieira Neto OM; Reis MA; Rodrigues Júnior AL; Ribeiro RA; Ravinal RC; Dantas M
    Clin Nephrol; 2009 Dec; 72(6):473-81. PubMed ID: 19954725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-center experience with cyclosporine in refractory nephrotic syndrome in children.
    Singh A; Tejani C; Tejani A
    Pediatr Nephrol; 1999 Jan; 13(1):26-32. PubMed ID: 10100285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
    Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
    Singh RG; Usha ; Rathore SS; Behura SK; Singh NK
    Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.